| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.37 | 0.01 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.32 | 0.05 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.27 | 0.09 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.27 | 5e-11 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.24 | 0.0002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.23 | 7e-06 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.23 | 0.0004 |